Receipt of the Independent Investigation Committee's Investigation Report
Wel-Dish.Incorporated
The former representative director's stock option exercise process, etc.
The accounting auditor pointed out potential issues with, among other matters, the former representative director's stock option exercise process.
Company response
Independent Investigation Committee. The committee was established and its members appointed on 22 April 2026. It consists solely of neutral and fair external experts independent of the Company. Chairperson's name: Not disclosed
We will formulate effective measures to prevent recurrence and implement them steadily.
The Company will anonymize the report and take other measures to protect confidential information, including personal information and information concerning business partners, and will promptly disclose the disclosed version of the investigation report once received. The Company will analyze and review the investigation results and recommendations, reflect them in management, and formulate and implement measures to prevent recurrence.
The Company expects to receive the disclosed version of the investigation report, with anonymization and other measures applied, within the next few days and will promptly disclose it upon receipt.
| Item | Details |
|---|---|
| Event name | Receipt of the Independent Investigation Committee's Investigation Report |
| Date of occurrence | 3 August 2026 (the date on which the investigation report was received from the Independent Investigation Committee) |
| Date recognized / date notice received | 3 August 2026 |
| Subject Entity | Wel-Dish.Incorporated |
| Target Locations / Products | The former representative director's stock option exercise process, etc. |
| Cause | The accounting auditor pointed out potential issues with, among other matters, the former representative director's stock option exercise process. |
| Investigation structure | Independent Investigation Committee. The committee was established and its members appointed on 22 April 2026. It consists solely of neutral and fair external experts independent of the Company. Chairperson's name: Not disclosed |
| Measures to prevent recurrence | We will formulate effective measures to prevent recurrence and implement them steadily. |
| Outlook | The Company will anonymize the report and take other measures to protect confidential information, including personal information and information concerning business partners, and will promptly disclose the disclosed version of the investigation report once received. The Company will analyze and review the investigation results and recommendations, reflect them in management, and formulate and implement measures to prevent recurrence. |
| Planned follow-up disclosure | The Company expects to receive the disclosed version of the investigation report, with anonymization and other measures applied, within the next few days and will promptly disclose it upon receipt. |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company's accounting auditor pointed out potential issues with, among other matters, the stock option exercise process, prompting the Company to identify the root causes, investigate matters outside the scope of the initial inquiry, and formulate measures to prevent recurrence. The Company will anonymize the investigation report and take other measures to protect confidential information, including personal information and business partner information, when disclosing it.